PPBT · Purple Biotech Ltd.
$1.39
+0.06 (+4.51%)
At close · Jul 23
Market Cap
$1.33M
Shares
932,274
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.39
Open$1.34
Day$1.34–1.39
52W$1.33–29.00
Avg vol 30d412K
Short int18K · 2.0% float · 1.0d
Short vol31%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−72%
below
Price vs 50-day avg
−39%
below
RSI (14)
31
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−21%
trailing
6-month return
−78%
trailing
YTD return
−79%
this year
Relative strength
−84%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $5 — 200d above 50d
Institutional flow
Distributing
2 of 15 funds reported for Jun 30 · net -136 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.96% of float · ▼ -32.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 1-yr range
Squeeze score
39
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
132%
annualized · 1-yr
Max drawdown
−95%
past year
ATR
10.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−72%
Bearish
Price vs 50-day avg
−39%
Bearish
RSI (14)
31
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $5 — 200d above 50d
Institutional flow
Distributing
2 of 15 funds reported for Jun 30 · net -136 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.96% of float · ▼ -32.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 0%
52-wk high $29
vs 200-day avg -72%
vs 50-day avg -39%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PPBT
this stock
Purple Biotech Ltd.
|
$1.33M | -78.9% | — | — | 2.0% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
14
- % held
- 8.1%
- Reported
- 2 of 15
- Top holder
- SUSQUEHANNA INTERNATIONAL…
Held
Float
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PPBT | -5.4% | -20.6% | -77.7% | -17.3% | -78.9% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -3.8% | -21.2% | -84.1% | -16.1% | -87.1% |